SME Central
Home / Moved to Main Board / Par Drugs And Chemicals

Par Drugs And Chemicals: IPO, Share Price and Results Since Listing

Par Drugs And Chemicals moved from NSE Emerge to the NSE main board on 16 September 2021. For Q2 FY2027 it reported revenue of INR 27.43 crore (-4.28% on a year earlier) and a profit after tax of INR 2.63 crore.

Key Facts

Moved to
NSE main board on 16 September 2021
Symbol
PAR
Latest close
INR 115.54 on 16 November 2026

Results Filed With NSE

Standalone figures, INR crore. Change compares with the same period a year earlier.

PeriodRevenueChangeProfit after taxEPS (INR)Filed
Q2 FY202727.43-4.28%2.632.14main board29 October 2026
Q1 FY202731.28+20.10%4.713.83main board8 August 2026
Q4 FY202619.61-12.18%0.850.69main board14 May 2026
FY2026103.66+2.66%13.1110.65main board14 May 2026
Q3 FY202629.34–4.803.90main board10 February 2026
Q2 FY202628.66–4.133.36main board13 November 2025
Q1 FY202626.05–3.332.70main board7 August 2025
Q4 FY202522.33–1.651.34main board8 May 2025
FY2025100.97–13.3610.86main board8 May 2025

Promoter Holding

Promoter holding has moved from 73.86% on 30 September 2021 to 73.41% on 30 September 2026 (-0.45 percentage points).

As ofPromotersPublic
30 September 202673.41%26.59%
30 June 202673.41%26.59%
31 March 202673.41%26.59%
31 December 202573.41%26.59%
30 September 202573.37%26.63%
30 June 202573.37%26.63%
31 March 202573.37%26.63%
31 December 202473.37%26.63%
30 September 202473.37%26.63%
30 June 202474.21%25.79%
31 March 202474.21%25.79%
31 December 202374.21%25.79%
30 September 202374.21%25.79%
30 June 202374.21%25.79%
31 March 202374.21%25.79%
31 December 202274.21%25.79%
30 September 202274.21%25.79%
30 June 202274.21%25.80%
31 March 202274.21%25.80%
31 December 202173.98%26.02%
30 September 202173.86%26.13%

Sources: NSE filings (results XBRL, shareholding pattern, board meetings), NSE daily price files, and IPO records. Prices are not adjusted for bonus issues or splits.